India to Ethiopia: Actinomycin Export Trade Route
India has recorded 11 verified shipments of Actinomycin exported to Ethiopia, representing a combined trade value of $36.0K USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $3.3K USD. The leading Indian exporter is VENUS REMEDIES LIMITED , which accounts for 71% of total export value with 2 shipments worth $25.4K USD. On the buying side, ETHIOPIAN PHARMACEUTICALS is the largest importer in Ethiopia with $25.4K USD in purchases. The top 3 suppliers — VENUS REMEDIES LIMITED , VIVIORA LIFESCIENCES PRIVATE LIMITED, MATOSHREE HEALTHCARE PVT LTD — together control 96% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Ethiopia Actinomycin corridor is one of India's established pharmaceutical export routes, with 11 shipments documented worth a combined $36.0K USD. The route is dominated by VENUS REMEDIES LIMITED , which alone accounts for roughly 71% of all export value, reflecting the consolidated nature of India's actinomycin manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $3.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with actinomycin's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 25.1%, placing it at rank #16 among India's top actinomycin export destinations globally.
On the import side, key buyers of Indian actinomycin in Ethiopia include ETHIOPIAN PHARMACEUTICALS , ETHIOPIAN PHARMACEUTICALS SUPPLY, ETHIOPIA ETHIOPIA ETHIOPIA ETHIOPIA ADDIS ABABA and 1 others. ETHIOPIAN PHARMACEUTICALS is the single largest importer with 2 shipments valued at $25.4K USD.
